S&P 500   2,472.65 (-4.33%)
DOW   21,025.66 (-4.07%)
QQQ   183.62 (-3.56%)
AAPL   243.49 (-4.25%)
FB   160.42 (-3.82%)
MSFT   152.91 (-3.04%)
GOOGL   1,109.47 (-4.52%)
AMZN   1,908.35 (-2.12%)
CGC   13.56 (-6.03%)
NVDA   251.96 (-4.42%)
BABA   187.19 (-3.75%)
MU   40.23 (-4.35%)
GE   7.19 (-9.33%)
TSLA   495.32 (-5.47%)
AMD   44.56 (-2.02%)
T   27.95 (-4.12%)
F   4.43 (-8.48%)
NFLX   362.34 (-3.50%)
BAC   19.76 (-6.97%)
GILD   72.89 (-2.50%)
PRI   83.89 (-5.69%)
DIS   94.73 (-1.94%)
S&P 500   2,472.65 (-4.33%)
DOW   21,025.66 (-4.07%)
QQQ   183.62 (-3.56%)
AAPL   243.49 (-4.25%)
FB   160.42 (-3.82%)
MSFT   152.91 (-3.04%)
GOOGL   1,109.47 (-4.52%)
AMZN   1,908.35 (-2.12%)
CGC   13.56 (-6.03%)
NVDA   251.96 (-4.42%)
BABA   187.19 (-3.75%)
MU   40.23 (-4.35%)
GE   7.19 (-9.33%)
TSLA   495.32 (-5.47%)
AMD   44.56 (-2.02%)
T   27.95 (-4.12%)
F   4.43 (-8.48%)
NFLX   362.34 (-3.50%)
BAC   19.76 (-6.97%)
GILD   72.89 (-2.50%)
PRI   83.89 (-5.69%)
DIS   94.73 (-1.94%)
S&P 500   2,472.65 (-4.33%)
DOW   21,025.66 (-4.07%)
QQQ   183.62 (-3.56%)
AAPL   243.49 (-4.25%)
FB   160.42 (-3.82%)
MSFT   152.91 (-3.04%)
GOOGL   1,109.47 (-4.52%)
AMZN   1,908.35 (-2.12%)
CGC   13.56 (-6.03%)
NVDA   251.96 (-4.42%)
BABA   187.19 (-3.75%)
MU   40.23 (-4.35%)
GE   7.19 (-9.33%)
TSLA   495.32 (-5.47%)
AMD   44.56 (-2.02%)
T   27.95 (-4.12%)
F   4.43 (-8.48%)
NFLX   362.34 (-3.50%)
BAC   19.76 (-6.97%)
GILD   72.89 (-2.50%)
PRI   83.89 (-5.69%)
DIS   94.73 (-1.94%)
S&P 500   2,472.65 (-4.33%)
DOW   21,025.66 (-4.07%)
QQQ   183.62 (-3.56%)
AAPL   243.49 (-4.25%)
FB   160.42 (-3.82%)
MSFT   152.91 (-3.04%)
GOOGL   1,109.47 (-4.52%)
AMZN   1,908.35 (-2.12%)
CGC   13.56 (-6.03%)
NVDA   251.96 (-4.42%)
BABA   187.19 (-3.75%)
MU   40.23 (-4.35%)
GE   7.19 (-9.33%)
TSLA   495.32 (-5.47%)
AMD   44.56 (-2.02%)
T   27.95 (-4.12%)
F   4.43 (-8.48%)
NFLX   362.34 (-3.50%)
BAC   19.76 (-6.97%)
GILD   72.89 (-2.50%)
PRI   83.89 (-5.69%)
DIS   94.73 (-1.94%)
Log in

ASX:RAP - Resapp Health Stock Price, Forecast & News

A$0.20
+0.01 (+5.26 %)
(As of 04/1/2020 02:28 PM ET)
Add
Compare
Today's Range
A$0.20
Now: A$0.20▼
A$0.23
50-Day Range
A$0.07
MA: A$0.18▼
A$0.26
52-Week Range
A$0.06
Now: A$0.20▼
A$0.42
Volume8.11 million shs
Average VolumeN/A
Market Capitalization$145.21 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company delivers mobile software apps in various clinical settings, including telehealth, emergency, urgent care, and primary care. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.
Read More

Industry, Sector and Symbol

Stock Exchange ASX
Industry Health Information Services
Sub-IndustryN/A
SectorMedical
Current SymbolASX:RAP
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.resapphealth.com.au/
Phone61 7 3724 0035

Debt

Debt-to-Equity Ratio8.24
Current Ratio2.62
Quick Ratio2.56

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$59,224.00
Price / Sales2,451.81
Cash FlowA$0.01 per share
Price / Cash Flow23.33
Book ValueA$0.01 per share
Price / Book28.57

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares726,028,992
Market Cap$145.21 million
Next Earnings DateN/A
OptionableNot Optionable

Receive RAP News and Ratings via Email

Sign-up to receive the latest news and ratings for RAP and its competitors with MarketBeat's FREE daily newsletter.


Resapp Health (ASX:RAP) Frequently Asked Questions

Has Resapp Health been receiving favorable news coverage?

News coverage about RAP stock has trended extremely negative on Wednesday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Resapp Health earned a coverage optimism score of -4.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View the latest news aboutResapp Health.

Who are some of Resapp Health's key competitors?

Who are Resapp Health's key executives?

Resapp Health's management team includes the following people:
  • Dr. Anthony Keating, CEO, MD & Director
  • Ms. Kay Taylor Ph.D., VP of Strategic Devel. & Operations
  • Dr. Udantha Abeyratne, Chief Scientist & Scientific Advisor
  • Ms. Nicki Farley, Company Sec. (Age 43)
  • Dr. Clas Källander, Founder and Director of R&D of Cavidi AB

What is Resapp Health's stock symbol?

Resapp Health trades on the ASX under the ticker symbol "RAP."

What is Resapp Health's stock price today?

One share of RAP stock can currently be purchased for approximately A$0.20.

How big of a company is Resapp Health?

Resapp Health has a market capitalization of $145.21 million and generates $59,224.00 in revenue each year.  View additional information about Resapp Health.

What is Resapp Health's official website?

The official website for Resapp Health is http://www.resapphealth.com.au/.

How can I contact Resapp Health?

The company can be reached via phone at 61 7 3724 0035.


MarketBeat Community Rating for Resapp Health (ASX RAP)

Community Ranking:  2.8 out of 5 (star star half star)
Outperform Votes:  5 (Thanks for Voting!)
Underperform Votes:  4 (Thanks for Voting!)
Total Votes:  9
MarketBeat's community ratings are surveys of what our community members think about Resapp Health and other stocks. Vote "Outperform" if you believe RAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Featured Article: Investing strategies using the yield curve
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel